Related Experiment Videos
Catecholaminergic suppression of immunocompetent cells
J Bergquist1, A Tarkowski, A Ewing
1Institute of Clinical Neuroscience, Dept of Psychiatry and Neurochemistry. jonas.bergquist@ms.se
Immunology Today
|December 29, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A proteomics perspective on 2 years of high-intensity training in horses: a pilot study.
Scientific reports·2024
A metabolomics perspective on 2 years of high-intensity training in horses.
Scientific reports·2024
Efficacy of incisional negative pressure therapy in preventing post-sternotomy wound complications.
American journal of surgery·2023
A simplified and sensitive immunoprecipitation mass spectrometry protocol for the analysis of amyloid-beta peptides in brain tissue.
Clinical mass spectrometry (Del Mar, Calif.)·2021
The origin and significance of anti-DNA antibodies.
Immunology today·2014
Mutations of class II MHC molecules.
Immunology today·2014
Antigen processing at the molecular level.
Immunology today·2014
Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.
Immunology today·2014
Are MHC class II-restricted cytotoxic T lymphocytes important?
Immunology today·2014
Complement and the regulation of humoral immune responses.
Immunology today·2014
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026